In support of this finding, PrognoScan, a new microarray database [11], and other recent studies [12–14] have demonstrated that human FAT4 gene expression is repressed in breast and lung cancers and in melanoma, which suggests that reduced FAT4 gene expression can trigger carcinogenesis. This evidence concerns the gene FAT4 and lung cancer.